LifeMD, Inc. to Announce Year End 2021 Financial Results and Host Conference Call on Monday, March 7

Rhea-AI Summary

LifeMD, Inc. (NASDAQ: LFMD) announced it will release its financial results for the year ending December 31, 2021, on March 7, 2022, after market close. The company will hold a conference call at 4:30 PM ET to discuss these results and provide a corporate update. LifeMD is a growing telehealth company offering virtual care across 50 states, utilizing a proprietary tech platform and pharmacy network to enhance healthcare accessibility.

NEW YORK, Feb. 22, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a rapidly growing direct-to-patient telehealth company, today announced that it will report its financial results for the year ended December 31, 2021 after the market close on Monday, March 7, 2022. Management will also host a conference call with investors to discuss financial results and provide a corporate update at 4:30pm Eastern Time.

Conference Call & Webcast Details:
Date:	Monday, March 7
Time:	4:30pm ET
Toll Free:	1-877-705-6003
International:	1-201-493-6725
Conference ID:	13727334
Webcast:	https://viavid.webcasts.com/starthere.jsp?ei=1531128&tp_key=11506307b8

About LifeMD
LifeMD is a 50-state direct-to-patient telehealth company with a portfolio of brands that offer virtual primary care, diagnostics, and specialized treatment for men’s and women’s health, allergy & asthma, and dermatological conditions. By leveraging its proprietary technology platform, 50-state medical group, and nationwide mail-order pharmacy network, LifeMD is increasing access to top-notch healthcare that is affordable to anyone. To learn more, go to LifeMD.com.

Cautionary Note Regarding Forward Looking Statements
This news release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended; Section 21E of the Securities Exchange Act of 1934, as amended; and the safe harbor provision of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this news release may be identified by the use of words such as: “believe,” “expect,” “anticipate,” “project,” “should,” “plan,” “will,” “may,” “intend,” “estimate,” “predict,” “continue,” and “potential,” or, in each case, their negative or other variations or comparable terminology referencing future periods. Examples of forward-looking statements include, but are not limited to, statements regarding our financial outlook and guidance, short and long-term business performance and operations, future revenues and earnings, regulatory developments, legal events or outcomes, ability to comply with complex and evolving regulations, market conditions and trends, new or expanded products and offerings, growth strategies, underlying assumptions, and the effects of any of the foregoing on our future results of operations or financial condition.

Forward-looking statements are not historical facts and are not assurances of future performance. Rather, these statements are based on our current expectations, beliefs, and assumptions regarding future plans and strategies, projections, anticipated and unanticipated events and trends, the economy, and other future conditions, including the impact of any of the aforementioned on our future business. As forward-looking statements relate to the future, they are subject to inherent risk, uncertainties, and changes in circumstances and assumptions that are difficult to predict, including some of which are out of our control. Consequently, our actual results, performance, and financial condition may differ materially from those indicated in the forward-looking statements. These risks and uncertainties include, but are not limited to, “Risk Factors” identified in our filings with the Securities and Exchange Commission, including, but not limited to, our most recently filed Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and any amendments thereto. Even if our actual results, performance, or financial condition are consistent with forward-looking statements contained in such filings, they may not be indicative of our actual results, performance, or financial condition in subsequent periods.

Any forward-looking statement made in the news release is based on information currently available to us as of the date on which this release is made. We undertake no obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except as may be required under applicable law or regulation.

Company Contact
LifeMD, Inc.
Marc Benathen, CFO
marc@lifemd.com

Investor Relations Contact
Ashley Robinson
LifeSci Advisors, LLC
arr@lifesciadvisors.com

Media Contact
Eric Herman
Kivvit
eherman@kivvit.com

FAQ

When will LifeMD report its financial results for 2021?

LifeMD will report its financial results for the year ended December 31, 2021, after market close on March 7, 2022.

What time is the LifeMD conference call scheduled?

The LifeMD conference call is scheduled for 4:30 PM ET on March 7, 2022.

What is the ticker symbol for LifeMD?

LifeMD's ticker symbol is LFMD.

How can I access the LifeMD conference call?

You can access the LifeMD conference call by dialing 1-877-705-6003 for toll-free or 1-201-493-6725 for international calls, using the conference ID 13727334.

What is LifeMD's business focus?

LifeMD focuses on providing direct-to-patient telehealth services, including virtual primary care and specialized treatments across various health areas.